[Some pharmacodynamical properties of niaprazine, a new antihistaminic agent].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000374:Aggression / Q000187:drug effects; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002490:Central Nervous System / Q000187:drug effects*; D005260:Female; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009536:Niacinamide / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D012702:Serotonin Antagonists
D000317:Adrenergic alpha-Antagonists; D006634:Histamine H1 Antagonists; D010879:Piperazines; D012702:Serotonin Antagonists; D009536:Niacinamide; D001920:Bradykinin
De quelques propriétés pharmacodynamiques de la niaprazine, nouvel antihistaminique.